Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of January 2019. The report announces a Special Meeting of Shareholders scheduled for March 4, 2019, at the company's offices in Petach-Tikva, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely to notify shareholders of an upcoming meeting and does not contain financial performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing.
Guidance, Outlook, and Corporate Actions
- Special Meeting: The Company will hold a Special Meeting of Shareholders on March 4, 2019, at 4:00 P.M. Israel time.
- Voting Materials: The filing includes a Notice and Proxy Statement (Exhibit 99.1), a Proxy Card for ordinary share holders (Exhibit 99.2), and a Voting Instruction Card for American Depositary Share holders (Exhibit 99.3).
- Proposal Details: The filing references a proposal to be voted upon but does not specify the nature of the proposal within the body text of this summary.
Key Facts for Investor Verification
- Verify the specific proposal to be voted on by reviewing the attached Notice and Proxy Statement (Exhibit 99.1).
- Confirm the record date for shareholder eligibility, which is not stated in this summary text.
- Check the company's latest financial reports (Form 20-F) for current liquidity and cash position, as this filing contains no financial data.